PFKFB3 and Sepsis: We then evaluated the therapeutic effect of miR-106a-5p against sepsis and found that treatment with agomir-miR-106a-5p, by reducing Pfkfb3 levels, was able to alleviate macrophage pyroptosis, inflammatory response, and lung injury in a lipopolysaccharide (LPS)-induced sepsis mouse model.